Salvador
Martín Algarra
Consultor Médico
Hospital Ramón y Cajal
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Ramón y Cajal (10)
2024
-
Access to melanoma drugs in Spain: a cross-sectional survey
Clinical and Translational Oncology, Vol. 26, Núm. 10, pp. 2572-2583
-
Access to systemic treatment of non-melanoma skin cancer in Spain: a survey analysis
Clinical and Translational Oncology
2023
-
SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registry
Clinical and Translational Oncology, Vol. 25, Núm. 3, pp. 768-775
2020
-
Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumors
Science Translational Medicine, Vol. 12, Núm. 565
2017
-
Highlights of the season 2016-2017 by the Spanish Melanoma Group (GEM)
Annals of Translational Medicine, Vol. 5, Núm. 19
-
Infomelanoma 2020: An online digital application designed to assist health professionals for melanoma treatment
Annals of Translational Medicine, Vol. 5, Núm. 19, pp. 1-9
-
Predictive factors of response to immunotherapy-a review from the Spanish Melanoma Group (GEM)
Annals of Translational Medicine, Vol. 5, Núm. 19
2016
-
Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: A retrospective study of the Grupo Español Multidisciplinar de Melanoma - Prima study
Melanoma Research, Vol. 26, Núm. 3, pp. 278-283
2015
-
Frequency and characteristics of familial melanoma in Spain: The FAM-GEM-1 study
PLoS ONE, Vol. 10, Núm. 4
2014
-
Melanoma: Diagnosis, Staging, and Treatment. Consensus group recommendations
Advances in Therapy, Vol. 31, Núm. 9, pp. 945-960